Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 48 | 39 | −9 |
| Shares | 20.7M | 19.6M | −1.12M (−5.4%) |
| Value | $59.0M | $60.7M | +$1.71M (+2.9%) |
New holders (2)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 194 | $601 | 0.00% |
| Oliver Lagore Vanvalin Investment Group | 100 | $310 | 0.00% |
Sold out (11)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Point72 Asset Management, L.P. | 232,659 | $663.1K |
| Renaissance Technologies LLC | 108,766 | $310.0K |
| Two Sigma Investments, LP | 52,186 | $148.7K |
| HighTower Advisors, LLC | 31,000 | $88.0K |
| Two Sigma Advisers, LP | 25,700 | $73.2K |
| Susquehanna International Group, LLP | 23,261 | $66.3K |
| Cubist Systematic Strategies, LLC | 12,957 | $36.9K |
| Virtu Financial LLC | 11,743 | $33.0K |
| Simplex Trading, LLC | 3,588 | $10.0K |
| Tower Research Capital LLC (TRC) | 172 | $490 |
| ICA Group Wealth Management, LLC | 100 | $285 |